Wider Approval for Cystic Fibrosis 'Miracle' Drug

The MHRA extended the licence for Kaftrio, a disease-modulating therapy for cystic fibrosis, to children under 12.

Related Keywords

United Kingdom ,Northern Ireland ,Craigavon ,Scotland ,Great Britain ,Amanda Pritchard ,Andrew Wilfin ,June Raine ,David Ramsden ,National Institute For Health ,Kaftrio Vertex Pharmaceuticals ,Cystic Fibrosis ,Vertex Pharmaceuticals Europe ,Regulatory Agency ,Vertex Pharmaceuticals ,Cystic Fibrosis Trust ,Changing Drug ,Medscape United Kingdom ,National Institute ,Care Excellence ,United Kingdom Cystic Fibrosis Registry ,Ireland Medical Director ,Children ,Child ,Childhood ,Ediatrics ,Kids ,Uk National Health Service ,United Kingdom National Health Service ,K Nhs ,Dhs ,National Health Service ,Uk Site Content United Kingdom ,Uk ,Menopause ,Menopausal Syndrome ,